CVA Family Office’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19K | Hold |
150
| – | – | ﹤0.01% | 699 |
|
|
2025
Q1 | $19.2K | Hold |
150
| – | – | ﹤0.01% | 685 |
|
|
2024
Q4 | $19.8K | Sell |
150
-225
| -60% | -$29.7K | ﹤0.01% | 678 |
|
|
2024
Q3 | $54.6K | Hold |
375
| – | – | 0.01% | 493 |
|
|
2024
Q2 | $51.5K | Hold |
375
| – | – | 0.01% | 490 |
|
|
2024
Q1 | $51.5K | Hold |
375
| – | – | 0.01% | 492 |
|
|
2023
Q4 | $50.9K | Buy |
+375
| New | +$50.9K | 0.01% | 468 |
|
|
2023
Q3 | – | Sell |
-375
| Closed | -$47.6K | – | 558 |
|
|
2023
Q2 | $47.6K | Hold |
375
| – | – | 0.01% | 460 |
|
|
2023
Q1 | $48.4K | Hold |
375
| – | – | 0.01% | 450 |
|
|
2022
Q4 | $49.2K | Hold |
375
| – | – | 0.01% | 425 |
|
|
2022
Q3 | $44K | Hold |
375
| – | – | 0.01% | 400 |
|
|
2022
Q2 | $44K | Hold |
375
| – | – | 0.01% | 394 |
|
|
2022
Q1 | $49K | Hold |
375
| – | – | 0.01% | 404 |
|
|
2021
Q4 | $57K | Buy |
375
+225
| +150% | +$34.2K | 0.01% | 335 |
|
|
2021
Q3 | $20K | Sell |
150
-225
| -60% | -$30K | 0.01% | 259 |
|
|
2021
Q2 | $61K | Hold |
375
| – | – | 0.02% | 333 |
|
|
2021
Q1 | $56K | Buy |
375
+203
| +118% | +$30.3K | 0.02% | 266 |
|
|
2020
Q4 | $26K | Buy |
172
+22
| +15% | +$3.33K | 0.02% | 250 |
|
|
2020
Q3 | $20K | Hold |
150
| – | – | 0.01% | 259 |
|
|
2020
Q2 | $21K | Hold |
150
| – | – | 0.02% | 217 |
|
|
2020
Q1 | $16K | Buy |
+150
| New | +$16K | 0.02% | 210 |
|